Fig 1.
Flow chart of the selection process based on the PRISMA statement [92].
Table 1.
General characteristics of included cost-effectiveness analyses and model-based economic evaluations.
Table 2.
General characteristics of included cost-of-illness analyses.
Table 3.
Cost-effectiveness analyses and model economic evaluations–health effects, costs, cost-effectiveness ratios and probabilities of cost-effectiveness.
Table 4.
Cost-of-illness analyses–Costs in categories and total costs per patient per year (in 2015 US$-PPP).